Genetic Technologies' Q2 Revenues Fall 23 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies in regulatory documents today said that receipts from customers declined 23 percent year over year during its fiscal second quarter.

For the three months ended Dec. 31, 2012, the Australian company took in A$4.1 million (US$4.3 million) in receipts, down from A$5.3 million in the year-ago period.

Its R&D spending was down 48 percent to A$21,400 from A$41,197 in the year ago period, while advertising and marketing costs were also cut 48 percent to A$217,493 from A$420,274.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."